chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Migraine, Pyrexia
Clinical narrative: migraine; Fever; Chill; red spot size of a tennis ball on her arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), PYREXIA (Fever), CHILLS (Chill) and INJECTION SITE ERYTHEMA (red spot size of a tennis ball on her arm) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MIGRAINE (migraine), PYREXIA (Fever), CHILLS (Chill) and INJECTION SITE ERYTHEMA (red spot size of a tennis ball on her arm). At the time of the report, MIGRAINE (migraine), PYREXIA (Fever), CHILLS (Chill) and INJECTION SITE ERYTHEMA (red spot size of a tennis ball on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Dysphonia
Clinical narrative: horseness; This spontaneous case was reported by a patient and describes the occurrence of DYSPHONIA (horseness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPHONIA (horseness). At the time of the report, DYSPHONIA (horseness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not provided by reporter, No concomitant medications were provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint pain), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness). At the time of the report, ARTHRALGIA (joint pain), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment and concomitant medications were not provided by reporter. Reporter did not allow further contact.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Oropharyngeal pain, Petechiae
Clinical narrative: petechiae on her right hand and forearm; Pain at injection site - left arm; Nausea; 102.4 fever; chills; severe body ache; sore throat; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache), OROPHARYNGEAL PAIN (sore throat) and PETECHIAE (petechiae on her right hand and forearm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL (ATACAND), SERTRALINE HYDROCHLORIDE (ZOLOFT), METOPROLOL TARTRATE (METOPROLOL [METOPROLOL TARTRATE]) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache) and OROPHARYNGEAL PAIN (sore throat). On an unknown date, the patient experienced PETECHIAE (petechiae on her right hand and forearm), VACCINATION SITE PAIN (Pain at injection site - left arm) and NAUSEA (Nausea). On 07-Feb-2021, PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache) and OROPHARYNGEAL PAIN (sore throat) had resolved. At the time of the report, PETECHIAE (petechiae on her right hand and forearm), VACCINATION SITE PAIN (Pain at injection site - left arm) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications for the events included Tylenol, Motrin, Vicodin and Ambien 5mg.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: petechiae on her right hand and forearm; Pain at injection site - left arm; Nausea; 102.4 fever; chills; severe body ache; sore throat; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache), OROPHARYNGEAL PAIN (sore throat) and PETECHIAE (petechiae on her right hand and forearm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL (ATACAND), SERTRALINE HYDROCHLORIDE (ZOLOFT), METOPROLOL TARTRATE (METOPROLOL [METOPROLOL TARTRATE]) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache) and OROPHARYNGEAL PAIN (sore throat). On an unknown date, the patient experienced PETECHIAE (petechiae on her right hand and forearm), VACCINATION SITE PAIN (Pain at injection site - left arm) and NAUSEA (Nausea). On 07-Feb-2021, PYREXIA (102.4 fever), CHILLS (chills), MYALGIA (severe body ache) and OROPHARYNGEAL PAIN (sore throat) had resolved. At the time of the report, PETECHIAE (petechiae on her right hand and forearm), VACCINATION SITE PAIN (Pain at injection site - left arm) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications for the events included Tylenol, Motrin, Vicodin and Ambien 5mg.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: arm is warm and feels hot; arm soreness; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm is warm and feels hot), VACCINATION SITE PAIN (arm soreness) and VACCINATION SITE ERYTHEMA (redness around the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Hip surgery. Concurrent medical conditions included Arthritis, Vision loss and Sulfonamide allergy. Concomitant products included NAPROXEN (NAPROSYN E) for Arthritis.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (arm is warm and feels hot), VACCINATION SITE PAIN (arm soreness) and VACCINATION SITE ERYTHEMA (redness around the injection site). At the time of the report, VACCINATION SITE WARMTH (arm is warm and feels hot), VACCINATION SITE PAIN (arm soreness) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: painful side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (painful side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (painful side effects). At the time of the report, VACCINATION SITE PAIN (painful side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash appears after 10 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash appears after 10 days) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 10-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Jan-2021, the patient experienced VACCINATION SITE RASH (rash appears after 10 days). At the time of the report, VACCINATION SITE RASH (rash appears after 10 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medications and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction. Concomitant products included Omeprazole, FOLIC ACID, IRON (PRENATAL [FOLIC ACID;IRON]), Insulin, METFORMIN, MONTELUKAST SODIUM (SINGULAIR), ACETYLSALICYLIC ACID (BABY ASPIRIN) and FERROUS SULFATE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Oct-2020 and the estimated date of delivery was date. On 22-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feels a little bit dizzy), NAUSEA (little bit nauseous) and VOMITING (vomited a little bit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history.). On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DIZZINESS (feels a little bit dizzy), NAUSEA (little bit nauseous) and VOMITING (vomited a little bit). At the time of the report, DIZZINESS (feels a little bit dizzy), NAUSEA (little bit nauseous) and VOMITING (vomited a little bit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment and concomitant medications were not provided by reporter. Reporter did not allow further contact.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: cough; runny nose; sore throat; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced RHINORRHOEA (runny nose) and OROPHARYNGEAL PAIN (sore throat). On 21-Jan-2021, the patient experienced COUGH (cough). At the time of the report, RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 34-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Supraventricular tachycardia in 1998 and Abortion spontaneous (Miscarriage was reported) on 02-Jan-2020. Concurrent medical conditions included Asthma since 2006. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, CLOMIPHENE CITRATE from 05-Jun-2020 to an unknown date for Subfertility, ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 08-Feb-2021 at 9:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 19-Mar-2021. On 08-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jul-2020, Pregnancy test: positive (Positive) Positive. On 12-Jan-2021, Ultrasound foetal: normal (normal) normal. On 26-Jan-2021, Ultrasound foetal: normal (normal) normal. On 05-Feb-2021, Ultrasound foetal: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reports having 2 previous pregnancies.  In 18-Mar-2018, the pregnancy outcome was Live, full-term birth.  The patient's estimated date of conception for the current pregnancy was 29-Jun-2020. Treatment medication was not reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Vaccination site pain
Clinical narrative: Woozy; Upset stomach; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woozy), ABDOMINAL DISCOMFORT (Upset stomach) and VACCINATION SITE PAIN (Arm pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DIZZINESS (Woozy), ABDOMINAL DISCOMFORT (Upset stomach) and VACCINATION SITE PAIN (Arm pain). On 29-Jan-2021, VACCINATION SITE PAIN (Arm pain) had resolved. At the time of the report, DIZZINESS (Woozy) and ABDOMINAL DISCOMFORT (Upset stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait disturbance, Illness, Vaccination complication
Clinical narrative: could barely walk to the room; sick; dizzy; didn't feel good and couldn't navigate; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could barely walk to the room), ILLNESS (sick), DIZZINESS (dizzy) and VACCINATION COMPLICATION (didn't feel good and couldn't navigate) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (could barely walk to the room), ILLNESS (sick), DIZZINESS (dizzy) and VACCINATION COMPLICATION (didn't feel good and couldn't navigate). At the time of the report, GAIT DISTURBANCE (could barely walk to the room), ILLNESS (sick), DIZZINESS (dizzy) and VACCINATION COMPLICATION (didn't feel good and couldn't navigate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Rash pruritic
Clinical narrative: severe reaction; chills; high fever; shaking, trembling; body aches; headache; rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling), MYALGIA (body aches), HEADACHE (headache) and RASH PRURITIC (rash). At the time of the report, VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling), MYALGIA (body aches), HEADACHE (headache) and RASH PRURITIC (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2021: Adverse events information was added.
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination complication
Clinical narrative: severe reaction; chills; high fever; shaking, trembling; body aches; headache; rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling), MYALGIA (body aches), HEADACHE (headache) and RASH PRURITIC (rash). At the time of the report, VACCINATION COMPLICATION (severe reaction), CHILLS (chills), PYREXIA (high fever), TREMOR (shaking, trembling), MYALGIA (body aches), HEADACHE (headache) and RASH PRURITIC (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2021: Adverse events information was added.
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Vaccination complication
Clinical narrative: Doesn't feel well; Migraine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (Migraine) and VACCINATION COMPLICATION (Doesn't feel well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced MIGRAINE (Migraine). On an unknown date, the patient experienced VACCINATION COMPLICATION (Doesn't feel well). At the time of the report, MIGRAINE (Migraine) and VACCINATION COMPLICATION (Doesn't feel well) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Itching at the injection site; Redness at the injection site, Redness about 3x4 inches; Warm at the injection site; Little pain at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (Little pain at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site, Redness about 3x4 inches) and VACCINATION SITE WARMTH (Warm at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011V201A) for COVID-19 vaccination.     No medical history was provided by reporter.     On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PAIN (Little pain at the injection site). On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site, Redness about 3x4 inches) and VACCINATION SITE WARMTH (Warm at the injection site). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) ongoing from 18-Jan-2021 at a dose of 1 dosage form. On 11-Jan-2021, VACCINATION SITE PAIN (Little pain at the injection site) had resolved. On 21-Jan-2021, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site, Redness about 3x4 inches) and VACCINATION SITE WARMTH (Warm at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Neck pain, Pyrexia, Vaccination site pain
Clinical narrative: Left arm pain; fever (103); Body ache; Neck pain; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE PAIN (Left arm pain), PYREXIA (fever (103)), MYALGIA (Body ache), NECK PAIN (Neck pain) and CHILLS (Chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm pain), PYREXIA (fever (103)), MYALGIA (Body ache), NECK PAIN (Neck pain) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Left arm pain), MYALGIA (Body ache), NECK PAIN (Neck pain) and CHILLS (Chills) had resolved and PYREXIA (fever (103)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Hypoaesthesia oral, Pharyngeal hypoaesthesia
Clinical narrative: Light numbness on the right side of my face; Tongue started to become numb/Bottom lip went numb; Throat started to become numb; Lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Tongue started to become numb/Bottom lip went numb), PHARYNGEAL HYPOAESTHESIA (Throat started to become numb), DIZZINESS (Lightheaded) and HYPOAESTHESIA (Light numbness on the right side of my face) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Tongue started to become numb/Bottom lip went numb), PHARYNGEAL HYPOAESTHESIA (Throat started to become numb) and DIZZINESS (Lightheaded). On 21-Jan-2021, the patient experienced HYPOAESTHESIA (Light numbness on the right side of my face). On 20-Jan-2021, HYPOAESTHESIA ORAL (Tongue started to become numb/Bottom lip went numb), PHARYNGEAL HYPOAESTHESIA (Throat started to become numb) and DIZZINESS (Lightheaded) had resolved. On 21-Jan-2021, HYPOAESTHESIA (Light numbness on the right side of my face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Sore arm; Severe headache; Chills; Fatigue/ very tired; Vomiting; Nigh sweats; severe muscle ache; wasn't feeling well; Sleeping; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting) and HYPERHIDROSIS (Nigh sweats) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting), HYPERHIDROSIS (Nigh sweats), MYALGIA (severe muscle ache), VACCINATION COMPLICATION (wasn't feeling well) and SOMNOLENCE (Sleeping). On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting), HYPERHIDROSIS (Nigh sweats), MYALGIA (severe muscle ache), VACCINATION COMPLICATION (wasn't feeling well), SOMNOLENCE (Sleeping) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination complication, Vaccination site pain, Vomiting
Clinical narrative: Sore arm; Severe headache; Chills; Fatigue/ very tired; Vomiting; Nigh sweats; severe muscle ache; wasn't feeling well; Sleeping; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting) and HYPERHIDROSIS (Nigh sweats) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting), HYPERHIDROSIS (Nigh sweats), MYALGIA (severe muscle ache), VACCINATION COMPLICATION (wasn't feeling well) and SOMNOLENCE (Sleeping). On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, HEADACHE (Severe headache), CHILLS (Chills), FATIGUE (Fatigue/ very tired), VOMITING (Vomiting), HYPERHIDROSIS (Nigh sweats), MYALGIA (severe muscle ache), VACCINATION COMPLICATION (wasn't feeling well), SOMNOLENCE (Sleeping) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Injection site was sore; It has become black and bluish; Site was red and bumpy; Bumpy; It started to itch; Big red mark 4-5 inches on my shoulder and arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm), VACCINATION SITE PAIN (Injection site was sore), VACCINATION SITE ERYTHEMA (Site was red and bumpy) and VACCINATION SITE URTICARIA (Bumpy) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm). On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE ERYTHEMA (Site was red and bumpy) and VACCINATION SITE URTICARIA (Bumpy). On 08-Feb-2021, the patient experienced VACCINATION SITE BRUISING (It has become black and bluish). On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site was sore). At the time of the report, VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm), VACCINATION SITE PAIN (Injection site was sore), VACCINATION SITE ERYTHEMA (Site was red and bumpy), VACCINATION SITE URTICARIA (Bumpy) and VACCINATION SITE BRUISING (It has become black and bluish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Injection site was sore; It has become black and bluish; Site was red and bumpy; Bumpy; It started to itch; Big red mark 4-5 inches on my shoulder and arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm), VACCINATION SITE PAIN (Injection site was sore), VACCINATION SITE ERYTHEMA (Site was red and bumpy) and VACCINATION SITE URTICARIA (Bumpy) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm). On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE ERYTHEMA (Site was red and bumpy) and VACCINATION SITE URTICARIA (Bumpy). On 08-Feb-2021, the patient experienced VACCINATION SITE BRUISING (It has become black and bluish). On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site was sore). At the time of the report, VACCINATION SITE PRURITUS (It started to itch), VACCINATION SITE RASH (Big red mark 4-5 inches on my shoulder and arm), VACCINATION SITE PAIN (Injection site was sore), VACCINATION SITE ERYTHEMA (Site was red and bumpy), VACCINATION SITE URTICARIA (Bumpy) and VACCINATION SITE BRUISING (It has become black and bluish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: hard red spot size of a silver dollar; hard spot; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (hard red spot size of a silver dollar), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE INDURATION (hard spot) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (hard red spot size of a silver dollar) and VACCINATION SITE INDURATION (hard spot). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itching). On 21-Jan-2021, VACCINATION SITE INDURATION (hard spot) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (hard red spot size of a silver dollar) was resolving and VACCINATION SITE PRURITUS (itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were nor provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: vaccine reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (vaccine reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccine reaction). At the time of the report, VACCINATION COMPLICATION (vaccine reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Injection site became red (2x2 inches round); Injection site warm; Injection site swollen; little tiny spots at the injection site; Itching at the injection site; little soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little soreness in her arm), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE SWELLING (Injection site swollen) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (little soreness in her arm). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE RASH (little tiny spots at the injection site). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE SWELLING (Injection site swollen). On 13-Jan-2021, VACCINATION SITE PAIN (little soreness in her arm) had resolved. On 20-Jan-2021, VACCINATION SITE PRURITUS (Itching at the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE RASH (little tiny spots at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included calamine lotion  and hydrocortisone cream. Concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Injection site became red (2x2 inches round); Injection site warm; Injection site swollen; little tiny spots at the injection site; Itching at the injection site; little soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little soreness in her arm), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE SWELLING (Injection site swollen) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (little soreness in her arm). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE RASH (little tiny spots at the injection site). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE SWELLING (Injection site swollen). On 13-Jan-2021, VACCINATION SITE PAIN (little soreness in her arm) had resolved. On 20-Jan-2021, VACCINATION SITE PRURITUS (Itching at the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Injection site became red (2x2 inches round)), VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE RASH (little tiny spots at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included calamine lotion  and hydrocortisone cream. Concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No relevant medical history reported). On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). At the time of the report, VACCINATION SITE PAIN (soreness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment and medication drugs were not provided by reporter. Reporter did not allow further contact.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: Light pink color developed over the vaccine site; Bump in the arm; Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Bump in the arm), VACCINATION SITE PAIN (Soreness in the arm) and VACCINATION SITE ERYTHEMA (Light pink color developed over the vaccine site) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included EZETIMIBE, SIMVASTATIN (VYTORIN), PLANTAGO OVATA (METAMUCIL REGULAR), LISINOPRIL, BIOTIN, VITAMIN B COMPLEX (B-COMPLEX [VITAMIN B COMPLEX]), IRON (IRON COMPLEX [IRON]), MULTIVITAMIN [VITAMINS NOS], CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]), TOCOPHEROL, UBIDECARENONE, ZINC (COENZYME Q10+), DOCUSATE SODIUM (COLACE), TURMERIC [CURCUMA LONGA RHIZOME], FINASTERIDE, PROBIOTICS NOS, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), FDgard, IBgard, METFORMIN HYDROCHLORIDE (METFORMIN ER), HYALURONIC ACID, Aspirin, ASCORBIC ACID (VITAMIN C ACID), CALCIUM, LEVOTHYROXINE and MAGNESIUM.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Bump in the arm) and VACCINATION SITE PAIN (Soreness in the arm). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Light pink color developed over the vaccine site). At the time of the report, VACCINATION SITE INDURATION (Bump in the arm), VACCINATION SITE PAIN (Soreness in the arm) and VACCINATION SITE ERYTHEMA (Light pink color developed over the vaccine site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medication were not provided by reporter.   This case was linked to MOD-2021-012030, MOD-2021-012030 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site rash
Clinical narrative: arm was painful; rash is bumpy; Rash is a little hard; red circle around the shot area - right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle around the shot area - right arm), VACCINATION SITE PAIN (arm was painful), VACCINATION SITE RASH (rash is bumpy) and VACCINATION SITE INDURATION (Rash is a little hard) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included ROSUVASTATIN and VITAMINS NOS for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle around the shot area - right arm), VACCINATION SITE RASH (rash is bumpy) and VACCINATION SITE INDURATION (Rash is a little hard). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm was painful). On 22-Jan-2021, VACCINATION SITE PAIN (arm was painful) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (red circle around the shot area - right arm), VACCINATION SITE RASH (rash is bumpy) and VACCINATION SITE INDURATION (Rash is a little hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.